tiprankstipranks
Ramsay Health Care (AU:RHC)
ASX:RHC
Australian Market

Ramsay Health Care (RHC) Earnings Dates, Call Summary & Reports

Compare
76 Followers

Earnings Data

Report Date
Aug 27, 2026
TBA (Confirmed)
Period Ending
2026 (Q4)
Consensus EPS Forecast
0.68
Last Year’s EPS
0.56
Same Quarter Last Year
Based on 8 Analysts Ratings

Earnings Call Summary

Q2 2026
Earnings Call Date:Feb 25, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented a majority of positive operating and financial developments, led by strong Australian revenue, admissions and profit growth, improved cash flow, disciplined capital allocation and refinancing wins. Material challenges remain in the U.K. (NHS funding weakness), underperforming Elysium operations, and funding/tariff pressures in France within Ramsay Santé, plus elevated consolidated debt and currency impacts. Management outlined credible mitigation actions and a clear transformation and capital‑discipline agenda to address the issues.
Company Guidance
Management guided FY26 toward continued Australia EBIT momentum after H1 underlying EBIT growth of 7.3% (Australia +7.1%) and underlying NPAT +8.1%; Australia H1 revenue from customers +8.2% (private portfolio +8.7%), admissions +3.1%, core surgical admissions +5.7%, inpatient acuity/IPDAs up, theater utilization +1.3% (12‑month rolling) and EBIT margins ex‑Joondalup +40bps. Group financial guidance: net financing costs $590–610m, underlying effective tax rate ~35%, operating cash flow of $350m in H1 (up 16.9%), consolidated net debt $5.1bn; Group CapEx reduced to $755–795m (development CapEx in Australia now $170–190m, 23 new theaters/procedure rooms scheduled in FY26 and H2 spend expected lower), dividend payout ratio 60–70% of underlying NPAT (interim fully franked $0.425/sh, +6.3%). Balance‑sheet metrics and program targets: Funding Group leverage excl. Sante 2.22x (target <2.5x), c.65–67% of debt hedged at ~3–3.65% average base, Ramsay Santé leverage 5.3x with EUR 391m liquidity, and the proposed Ramsay Santé in‑specie demerger expected to complete in December 2026.
Group Underlying Profit Growth
Underlying EBIT up 7.3% and underlying NPAT up 8.1% for the half, driven primarily by Australian operations and higher acuity across regions.
Strong Australian Revenue and Admissions
Revenue from customers in Australia increased 8.2%; revenue from the private hospital portfolio grew 8.7%. Hospital admissions rose 3.1% and core surgical admissions grew 5.7%, with higher-acuity case mix (IPDAs growing faster than admissions).
Margin and Utilization Improvements in Australia
EBIT margins (excluding Joondalup) improved by 40 basis points versus prior period; 12-month rolling theatre utilization increased ~1.3% despite new capacity additions.
Cashflow and Balance Sheet Improvements
Operating cash flow improved 16.9% to $350 million; Funding Group leverage (ex-Santé) is 2.22x, within target (<2.5x); weighted average cost of debt declined ~20 bps since 30 June 2025 following refinancing (syndicated facility margin down 30 bps).
Dividend and Capital Allocation Discipline
Board declared a fully franked interim dividend of $0.425 per share (+6.3%); payout ratio 60% of underlying earnings, and Group CapEx guidance reduced (now $755m–$795m) reflecting disciplined capital allocation.
Development and Capacity Additions
23 new theatres/procedure rooms scheduled to open in FY26 (major hospitals / key catchments); Australian development CapEx now expected $170m–$190m (below prior guidance) as projects are reprioritised and utilization optimized.
Operational and Clinical Initiatives
Multiyear transformation progress: improved patient/doctor/people NPS, 23% growth in clinical trials activity, targeted 'Big 5' hospital initiatives and pilot programs to drive cost efficiencies and One Ramsay digital/AI synergies.
Ramsay Santé and Nordics Performance
Ramsay Santé delivered a 4.4% increase in underlying EBIT in constant currency, driven by strong Nordic performance (notably Sweden) and a new favourable contract at St. Göran.
Liquidity and Hedging Position
Consolidated net debt $5.1bn with adequate liquidity for the National Capital Hospital acquisition; ~65–67% of floating exposure hedged (average base rates ~3.0–3.65%), and Ramsay Santé has EUR 391m liquidity available.

Ramsay Health Care (AU:RHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AU:RHC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 27, 2026
2026 (Q4)
0.68 / -
0.561
Feb 25, 2026
2026 (Q2)
0.60 / 0.71
0.6548.56% (+0.06)
Aug 27, 2025
2025 (Q4)
0.66 / 0.56
0.579-3.11% (-0.02)
Feb 26, 2025
2025 (Q2)
0.62 / 0.65
0.57912.95% (+0.08)
Aug 29, 2024
2024 (Q4)
0.63 / 0.58
0.42934.97% (+0.15)
Feb 28, 2024
2024 (Q2)
0.52 / 0.58
0.829-30.16% (-0.25)
Aug 23, 2023
2023 (Q4)
0.70 / 0.43
0.487-11.91% (-0.06)
Feb 23, 2023
2023 (Q2)
0.80 / 0.83
0.67722.45% (+0.15)
Aug 25, 2022
2022 (Q4)
0.66 / 0.49
0.96-49.27% (-0.47)
Feb 23, 2022
2022 (Q2)
0.92 / 0.68
0.969-30.13% (-0.29)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

AU:RHC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 25, 2026
AU$37.80AU$41.72+10.35%
Aug 27, 2025
AU$37.28AU$33.37-10.50%
Feb 26, 2025
AU$32.77AU$35.00+6.82%
Aug 29, 2024
AU$42.68AU$39.80-6.76%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Ramsay Health Care (AU:RHC) report earnings?
Ramsay Health Care (AU:RHC) is schdueled to report earning on Aug 27, 2026, TBA (Confirmed).
    What is Ramsay Health Care (AU:RHC) earnings time?
    Ramsay Health Care (AU:RHC) earnings time is at Aug 27, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Ramsay Health Care stock?
          The P/E ratio of Ramsay Health Care is N/A.
            What is AU:RHC EPS forecast?
            AU:RHC EPS forecast for the fiscal quarter 2026 (Q4) is 0.68.